Clopidogrel (WW) Pellets
Rraynex supplies Clopidogrel (WW) Pellets as pellets in the Antiplatelet category, in a strength of 30%.
Product overview
Clopidogrel is a P2Y12 antiplatelet agent used to prevent heart attack and stroke, often alongside aspirin in dual antiplatelet therapy.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Pharmaceutical applications
- Capsule filling of clopidogrel (ww) pellets for antiplatelet products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Clopidogrel (WW) Pellets
- Form
- Pellets
- Therapeutic category
- Antiplatelet
- Strength
- 30%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Clopidogrel (WW) Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Clopidogrel products from Rraynex
- Clopidogrel + Domperidone — Granules
- Clopidogrel + Pantoprazole — Granules
- Clopidogrel DC — Granules
- Aspirin + Clopidogrel (WW) — Pellets
- Atorvastatin + Clopidogrel — Pellets
- Clopidogrel — Pellets
- Clopidogrel + Aspirin — Pellets